Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhanced paper-based insulin titration protocol for glycaemic control in hospitalized type 2 diabetes patients
2011-001918-34Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- May 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin aspart and insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Medical University of Graz. Primary endpoint: Mean blood glucose per treatment day (premeal and bedtime values). Started May 2011; status: completed.
02
Drugs
insulin aspartinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-001918-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001918-34.